Literature DB >> 26048146

Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression.

Ming Gao1, Xiaohui Wang1, Xia Zhang1, Tuanzhu Ha2, He Ma1, Li Liu3, John H Kalbfleisch4, Xiang Gao5, Race L Kao2, David L Williams2, Chuanfu Li6.   

Abstract

Cardiac dysfunction is a major consequence of sepsis/septic shock and contributes to the high mortality of sepsis. Innate and inflammatory responses mediated by TLRs play a critical role in sepsis-induced cardiac dysfunction. MicroRNA-146 (miR-146) was first identified as a negative regulator in innate immune and inflammatory responses induced by LPS. This study examined whether miR-146a will have a protective effect on sepsis-induced cardiac dysfunction. Lentivirus-expressing miR-146a (LmiR-146a) or lentivirus-expressing scrambled miR (LmiR-control) was delivered into the myocardium via the right carotid artery. Seven days after transfection, mice were subjected to cecal ligation and puncture (CLP). Untransfected mice were also subjected to CLP-induced sepsis. Cardiac function was examined by echocardiography before and 6 h after CLP. In vitro studies showed that increased miR-146a levels suppress LPS-induced IκBα phosphorylation and inflammatory cytokine production in both H9C2 cardiomyocytes and J774 macrophages. In vivo transfection of LmiR-146a attenuated sepsis-induced cardiac dysfunction. The values for percent ejection fraction and percent fractional shortening in LmiR-146a-transfected CLP mice were significantly greater than in untransfected CLP control. LmiR-146a transfection prevented sepsis-induced NF-κB activity, suppressed IRAK and TRAF6 expression in the myocardium, and attenuated sepsis-induced inflammatory cytokine production in both plasma and peritoneal fluid. In addition, LmiR-146a transfection decreased sepsis-induced infiltration of neutrophils and macrophages into the myocardium. LmiR-146a can also transfect macrophages in the periphery. We conclude that miR-146a attenuates sepsis-induced cardiac dysfunction by preventing NF-κB activation, inflammatory cell infiltration, and inflammatory cytokine production via targeting of IRAK and TRAF6 in both cardiomyocytes and inflammatory monocytic cells.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26048146      PMCID: PMC4490963          DOI: 10.4049/jimmunol.1403155

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  MicroRNAs: the fine-tuners of Toll-like receptor signalling.

Authors:  Luke A O'Neill; Frederick J Sheedy; Claire E McCoy
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

Review 3.  MicroRNA-146a and human disease.

Authors:  L Li; X-P Chen; Y-J Li
Journal:  Scand J Immunol       Date:  2010-04       Impact factor: 3.487

Review 4.  Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility.

Authors:  Orna Avlas; Reut Fallach; Asher Shainberg; Eyal Porat; Edith Hochhauser
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

5.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

6.  Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury.

Authors:  Xiaohui Wang; Tuanzhu Ha; Li Liu; Jianghuan Zou; Xia Zhang; John Kalbfleisch; Xiang Gao; David Williams; Chuanfu Li
Journal:  Cardiovasc Res       Date:  2012-12-03       Impact factor: 10.787

7.  The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling.

Authors:  Ming Gao; Tuanzhu Ha; Xia Zhang; Xiaohui Wang; Li Liu; John Kalbfleisch; Krishna Singh; David Williams; Chuanfu Li
Journal:  J Infect Dis       Date:  2013-01-28       Impact factor: 5.226

8.  TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism.

Authors:  Tuanzhu Ha; Chen Lu; Li Liu; Fang Hua; Yulong Hu; Jim Kelley; Krishna Singh; Race L Kao; John Kalbfleisch; David L Williams; Xiang Gao; Chuanfu Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-08       Impact factor: 4.733

Review 9.  Toward microRNA-based therapeutics for heart disease: the sense in antisense.

Authors:  Eva van Rooij; William S Marshall; Eric N Olson
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

Review 10.  Adding fuel to fire: microRNAs as a new class of mediators of inflammation.

Authors:  F J Sheedy; L A J O'Neill
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

View more
  69 in total

Review 1.  Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.

Authors:  Muhammad Abdullah; Jessica M Berthiaume; Monte S Willis
Journal:  Transl Res       Date:  2017-11-07       Impact factor: 7.012

2.  Attenuation of Sepsis-Induced Cardiomyopathy by Regulation of MicroRNA-23b Is Mediated Through Targeting of MyD88-Mediated NF-κB Activation.

Authors:  Chao Cao; Yan Zhang; Yanfen Chai; Lijun Wang; Chengfen Yin; Songtao Shou; Heng Jin
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 3.  MiR-146a/b: a family with shared seeds and different roots.

Authors:  Mark R Paterson; Alison J Kriegel
Journal:  Physiol Genomics       Date:  2017-02-17       Impact factor: 3.107

4.  TGF-β1/Smad2/3/Foxp3 signaling is required for chronic stress-induced immune suppression.

Authors:  Haiju Zhang; Yi Caudle; Clay Wheeler; Yu Zhou; Charles Stuart; Baozhen Yao; Deling Yin
Journal:  J Neuroimmunol       Date:  2017-11-08       Impact factor: 3.478

Review 5.  [Epigenetics : Important aspects for anesthesiologists, pain and intensive care physicians].

Authors:  A-K Reinhold; E Jentho; S T Schäfer; M Bauer; H L Rittner
Journal:  Anaesthesist       Date:  2018-04       Impact factor: 1.041

6.  PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.

Authors:  Stephen W Standage; Brock G Bennion; Taft O Knowles; Dolena R Ledee; Michael A Portman; John K McGuire; W Conrad Liles; Aaron K Olson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-11-23       Impact factor: 4.733

Review 7.  Can the Cecal Ligation and Puncture Model Be Repurposed To Better Inform Therapy in Human Sepsis?

Authors:  John C Alverdy; Robert Keskey; Renee Thewissen
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

8.  MicroRNA-302a suppresses influenza A virus-stimulated interferon regulatory factor-5 expression and cytokine storm induction.

Authors:  Xueyuan Chen; Li Zhou; Nanfang Peng; Haisheng Yu; Mengqi Li; Zhongying Cao; Yong Lin; Xueyu Wang; Qian Li; Jun Wang; Yinglong She; Chengliang Zhu; Mengji Lu; Ying Zhu; Shi Liu
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

Review 9.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.

Authors:  Kobina Essandoh; Yutian Li; Jiuzhou Huo; Guo-Chang Fan
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

Review 10.  Contribution of MicroRNAs to autoimmune diseases.

Authors:  Lucien P Garo; Gopal Murugaiyan
Journal:  Cell Mol Life Sci       Date:  2016-03-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.